Kenvue Strategy and Business Model

Executive Overview

Kenvue is a global consumer health company that was separated from Johnson & Johnson in 2023 and sells branded everyday health products across over-the-counter medicines, skin health and beauty, oral care, baby care, wound care, and related personal care categories. Headquartered in Skillman, New Jersey, Kenvue operates through three reported segments: Self Care, Skin Health and Beauty, and Essential Health. Its portfolio includes brands such as Tylenol, Neutrogena, Aveeno, Listerine, Johnson’s, BAND-AID, Zyrtec, and Nicorette, giving it broad exposure to both daily-use and episodic health needs. Kenvue’s strategy is not to compete like a prescription drug company or a private-label manufacturer. It is trying to win in categories where trust, brand memory, consumer habits, retailer shelf presence, and product efficacy matter. In FY2024, Kenvue generated approximately $15.5 billion in net sales. Since becoming a standalone public company, its agenda has centered on completing the operational separation from Johnson & Johnson, improving execution in weaker parts of Skin Health and Beauty, investing behind priority brands and innovation, growing e-commerce and international markets, and expanding margins through pricing, mix, and productivity.

Kenvue at a Glance

Logo
Common name	Kenvue
Full legal name	Kenvue Inc.
Headquarters	Skillman, New Jersey, United States
Ownership	Publicly traded; broadly held institutional ownership
Ticker	KVUE
Exchange	NYSE - New York Stock Exchange
Market Cap	$35.32B
Revenue (FY2024)	$15.46B
Founding / major historical milestones	Created as a standalone company in 2023 through the separation of Johnson & Johnson’s Consumer Health business; portfolio heritage spans more than a century and includes brands built internally and through acquisitions such as Pfizer Consumer Healthcare (2006), Vogue International (2016), Zarbee’s (2018), and Dr.Ci:Labo parent Ci:z Holdings (2019).
Industry or industries	Consumer health; over-the-counter medicines; skin health and beauty; oral care; baby care; personal care
Key products or services	OTC pain relief, allergy and cough/cold products, smoking cessation, oral care, skin care, hair care, baby care, wound care, and women’s health products
Geographic footprint	Products sold in more than 165 countries and territories, with significant operations across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa
Business segments as officially reported	Self Care; Skin Health and Beauty; Essential Health
Company website	https://www.kenvue.com/

1. What Is the Strategy of Kenvue?

Kenvue’s public strategy, as reflected in its FY2024 filings and investor communications, is to build a focused standalone consumer health company around large, trusted brands in everyday care categories. The easiest way to understand that strategy is through the five questions in the Playing to Win framework.

1. 1a. What is the winning aspiration of Kenvue?

   Kenvue’s stated purpose is to “realize the extraordinary power of everyday care.” In practical terms, winning means turning a heritage consumer health portfolio into a consistently growing, higher-margin, cash-generative standalone public company. Management has emphasized sustainable profitable growth rather than sheer scale. In FY2024 communications, the company repeatedly framed success around organic sales growth, stronger execution, margin expansion, and durable cash generation. It does not present a single all-encompassing headline target in the annual report; instead, it defines winning through category leadership, stronger brand performance, improved operating discipline, and better shareholder returns over time.

2. 1b. Where does Kenvue play?

   Kenvue plays in global consumer health, specifically in branded everyday care categories where consumers buy products directly rather than through prescription channels. Its chosen arenas are Self Care, Skin Health and Beauty, and Essential Health. That means pain relief, allergy, cough/cold, smoking cessation, skin care, oral care, baby care, wound care, and women’s health. It plays through mass retail, drug, grocery, club, pharmacy, and e-commerce channels, and it operates in both developed and emerging markets. Just as important, Kenvue does not try to play everywhere: it is not a prescription pharmaceutical business, not a medical devices company, and not a pure private-label manufacturer.

3. 1c. How does Kenvue plan to win?

   Kenvue appears to plan to win through brand trust, science-backed product claims, wide distribution, and repeat purchase behavior. Many of its categories reward familiarity and confidence: consumers often repurchase the same pain reliever, mouthwash, baby product, or skin care brand once trust is established. Kenvue therefore competes on a combination of efficacy, brand memory, professional recommendation in certain categories, retailer execution, and omnichannel visibility. It is not primarily pursuing a lowest-cost position. Instead, its playbook is to defend and extend brand equity, launch line extensions and improved formulations, manage price-pack architecture carefully, and use global scale to support both innovation and shelf presence.

4. 1d. What capabilities must Kenvue have in place?

   To win this way, Kenvue needs several capabilities that fit branded consumer health rather than general packaged goods alone. These include strong brand building; consumer insights; formulation science and claims substantiation; regulatory, quality, and safety systems; retailer and pharmacy account management; demand forecasting for seasonal categories; global sourcing and manufacturing; and digital commerce execution. Since the 2023 separation from Johnson & Johnson, another required capability has been building standalone corporate systems, data, and shared services without damaging execution in the core business.

5. 1e. What management systems does Kenvue require?

   Kenvue needs management systems that reinforce brand investment discipline, quality compliance, pricing and promotion control, supply reliability, and cash conversion. In practice, that means category and brand-level performance management, formal innovation pipelines, strong regulatory and pharmacovigilance processes for OTC products, sales and operations planning, and tight working-capital oversight. As a newly independent company, it also requires transition governance to replace legacy Johnson & Johnson support arrangements, establish clear segment accountability, and make sure margin goals are not overwhelmed by stranded costs or execution drift.

2. What Are the Current Strategic Initiatives of Kenvue?

Based on Kenvue’s FY2024 disclosures and management commentary after the separation, the company’s agenda is relatively clear: stabilize execution, invest behind the strongest brands, complete the stand-up as an independent company, and improve profitability.

• Complete the post-separation stand-up. Kenvue became a standalone public company in 2023, but the operational separation from Johnson & Johnson has required multiyear work. That includes replacing transition services, building standalone information systems and support functions, and establishing a cost structure appropriate for an independent consumer health company. This is strategically important because it affects decision speed, accountability, and margins.
• Improve execution in Skin Health and Beauty, especially where performance lagged. A recurring theme in management commentary has been the need to improve commercial execution in Skin Health and Beauty, particularly in parts of the U.S. business. That initiative includes better innovation timing, stronger media support, tighter channel and promotional execution, and sharper portfolio management for brands such as Neutrogena and Aveeno.
• Concentrate investment on priority brands and higher-return innovation. Kenvue has been directing resources toward brands with the strongest global equity and category economics. For a company like Kenvue, innovation is usually not about breakthrough drug discovery; it is about line extensions, reformulations, new formats, premium offerings, packaging upgrades, and claims that can be supported scientifically and communicated clearly to consumers and retailers.
• Expand e-commerce and improve digital shelf execution. Consumer health increasingly depends on search visibility, ratings, content quality, and retailer media networks. Kenvue has been explicit about digital commerce as a growth area. The strategic task is not simply selling online; it is adapting content, pack architecture, fulfillment economics, and consumer targeting to omnichannel behavior.
• Drive margin improvement through pricing, mix, productivity, and simplification. Management has emphasized both top-line growth and operating discipline. That usually translates into revenue growth management, procurement savings, manufacturing and logistics productivity, SKU rationalization, and tighter trade-spend control. For Kenvue, improving margins matters because FY2024 still reflected the realities of standing up an independent public company.
• Grow in attractive international markets and underpenetrated segments. Kenvue already has broad global reach, but several brands still have whitespace in emerging markets, e-commerce, premium dermocosmetics, and recommendation-led categories. International expansion is therefore less about entering brand-new industries and more about transferring proven brands, formats, and go-to-market models across markets where the company already has some footprint.

3. What Is the Business Model of Kenvue?

What customers actually buy

Kenvue sells physical consumer health products, not services and not subscriptions. Immediate customers are retailers, pharmacies, wholesalers, distributors, and e-commerce platforms. End consumers buy pain relievers, allergy medicines, mouthwash, baby lotion, acne care, wound care products, and other everyday health items. In some categories, healthcare professionals influence demand, but the sale is still typically made through retail channels.

What portion of the model appears recurring or repeat-driven versus one-time

Kenvue has little contractual recurring revenue in the software sense. Its repeatability comes from consumer behavior. Oral care, skin care, baby care, and many personal care products are habitual purchases. OTC medicines are more episodic, but they still produce repeat demand because the brands are trusted and the underlying conditions recur. That creates a business with strong replenishment characteristics even without subscriptions.

How pricing power works, if at all

Kenvue has some pricing power because of brand trust, category leadership in certain products, and the relatively small ticket size of many items. A consumer deciding between mouthwashes or allergy products may not be highly price sensitive if the brand is familiar and effective. That said, pricing power is not unlimited. It is constrained by retailer negotiations, trade promotion intensity, private-label alternatives, consumer downtrading, and in some markets local regulatory considerations.

Why the business mix matters

Business mix matters because Kenvue’s segments have different economics. Self Care products often benefit from high trust and medically oriented positioning but can be seasonal. Essential Health tends to include steadier daily-use products such as oral care and baby care. Skin Health and Beauty offers premiumization and innovation upside, but it is also more exposed to merchandising, digital competition, and promotional pressure. A shift in mix can therefore change both growth quality and margins.

What drives gross margin, operating margin, and cash generation

Gross margin is driven by brand mix, pricing, commodity and packaging costs, manufacturing efficiency, and promotional intensity. Operating margin is then shaped by media spend, trade promotion, R&D and regulatory support, corporate overhead, and separation-related costs. Cash generation tends to be strong in branded consumer health because capital expenditure is usually modest relative to sales, but working capital still matters. Inventory planning, receivables discipline, and avoiding overstocks in seasonal categories are important.

Revenue model

The revenue model is fundamentally wholesale and distributor-based. Kenvue sells product into large retail and pharmacy accounts, wholesalers, and distributors, with some e-commerce sales occurring through retailer platforms and marketplaces. It is a repeat-purchase, branded packaged-goods model with elements of healthcare regulation and recommendation, rather than a subscription, rental, or usage-based model.

4. What Products and/or Services Does Kenvue Sell?

Kenvue is overwhelmingly a product company. Its offerings are grouped into three reported segments.

The most strategically important products are the large global brands that combine strong awareness with repeat usage and retailer clout. Tylenol, Zyrtec, Nicorette, Listerine, Johnson’s, Neutrogena, and Aveeno are especially important because they influence both scale and brand perception. Legacy brands still account for much of the economic engine, while newer or acquired growth platforms such as OGX, Maui Moisture, Zarbee’s, and Dr.Ci:Labo add category adjacency, premium exposure, or international depth.

5. What Are the Key Competitors or Peers of Kenvue?

No single competitor overlaps every Kenvue category. The company faces a different set of rivals by aisle, geography, and channel.

Private-label offerings are also an important competitive force, especially in OTC and basic personal care. In some categories, Kenvue is effectively competing not only against branded peers but also against retailer control of shelf space and digital search placement.

6. What Is the Marketing Strategy of Kenvue?

Kenvue’s marketing strategy is brand-led and category-specific. Because many of its products are bought on trust and habit, marketing is not a support function at the margin; it is central to the business model.

• Brand marketing is the foundation. Large legacy brands such as Tylenol, Neutrogena, Listerine, and Johnson’s need constant reinforcement through mass media, digital video, social, packaging, and in-store visibility. The goal is to keep brands salient in categories where purchase decisions are fast and shelf-level.
• Shopper marketing and trade promotion matter heavily. Because Kenvue sells through major retailers, marketing is also tied to merchandising, displays, circulars, retail media, search placement, assortment, and promotional calendars. In this sense, channel marketing is as important as consumer advertising.
• Performance marketing is increasingly important in e-commerce. For categories such as skin care and oral care, search rankings, content quality, ratings, reviews, and retailer-platform advertising can strongly affect conversion. Kenvue therefore needs sophisticated digital shelf management in addition to traditional media buying.
• Professional recommendation supports selected brands. In oral care, skin health, baby care, and some OTC categories, dentists, dermatologists, pediatricians, pharmacists, and other professionals can influence usage or brand trust. That makes scientific claims support and medical affairs capability important even though Kenvue is not a prescription-pharma company.

Overall, marketing appears to be a major differentiator for Kenvue. The company owns many old, well-known brands, but those brands still need active positioning, reformulation support, modern digital presentation, and disciplined promotion to remain competitive.

7. What Are the Key Customer Segments of Kenvue?

Kenvue serves both channel customers and end consumers. Those are not the same thing, and the distinction matters.

• Large mass retailers and club chains. These customers matter for volume, national shelf placement, trade promotion, and pricing negotiations.
• Drugstores and pharmacies. Especially important for OTC medicines and oral care, where health-oriented shopping missions are common.
• Grocery retailers. Relevant for everyday oral care, baby care, and certain OTC products.
• E-commerce platforms and omnichannel retailers. Increasingly important for skin care, hair care, oral care, and replenishment-oriented categories.
• Wholesalers and distributors. Important in smaller markets, fragmented channels, and certain international geographies.
• End consumers segmented by need state. Families buying baby products and wound care, adults managing pain or allergies, smokers seeking cessation, consumers shopping for acne or facial care, and households buying oral care are all key end markets.

Kenvue is diversified across multiple end markets, which is helpful. It is not dependent on a single end-use sector in the way an industrial supplier might be. But it is still exposed to concentration among large retail customers within major markets, especially in North America.

8. What Is the Sales Model of Kenvue?

Kenvue uses a classic branded consumer health sales model with omnichannel execution. It sells directly to many large retail, pharmacy, and e-commerce accounts; it also uses wholesalers and distributors where local market structure makes that more efficient.

• Direct key-account selling. Large customers typically require direct negotiation on assortment, pricing, trade terms, promotions, retail media, and merchandising.
• Distributor-based selling in some markets. In smaller or more fragmented geographies, distributors extend reach without requiring Kenvue to build a full direct sales force everywhere.
• Omnichannel selling. Products reach consumers through physical shelves, retailer websites, third-party marketplaces, and in some cases brand-owned digital properties, though Kenvue is not primarily a direct-to-consumer business.
• Category management and sell-through focus. Success depends not only on selling inventory into retailers but also on monitoring sell-through, keeping shelf position, and managing replenishment.

This channel structure affects growth and pricing in several ways. Retailers influence promotion intensity and shelf placement; e-commerce changes content and pack economics; and distributors can extend reach but reduce direct customer intimacy. It also creates natural consulting opportunities around revenue growth management, channel strategy, e-commerce operating models, assortment optimization, and trade-spend effectiveness.

9. In What Geographies Does Kenvue Operate?

Kenvue sells products in more than 165 countries and territories. The company is geographically diversified, although North America remains its most important market.

• North America. The United States is the largest single market and an operational center for many flagship brands. Canada is also an established market.
• Europe, Middle East, and Africa. Kenvue has a broad presence in Europe across self-care, oral care, and personal care categories, with additional activity across the Middle East and Africa through local subsidiaries and distributor networks.
• Asia-Pacific. Japan is strategically important because of premium skin care exposure through Dr.Ci:Labo. China, India, and Southeast Asia matter for long-term growth, especially in skin health, self-care, and oral care.
• Latin America. The region is important for daily-use health and personal care categories and offers both scale and growth potential in markets such as Brazil and Mexico.

Operationally, Kenvue combines global brand management with regional commercial execution and a geographically dispersed supply network. It does not report geographic operating segments as its primary structure; instead, it reports category-based segments and provides geographic disclosures in its filings.

10. Who Are the Owners of Kenvue?

Kenvue is a public company listed on the New York Stock Exchange. Following Johnson & Johnson’s 2023 split-off of Kenvue shares, Kenvue became widely held rather than controlled by a parent company.

In public ownership filings after the separation, large institutional shareholders have included major index managers such as The Vanguard Group, BlackRock, and State Street. No controlling shareholder is a defining feature of the ownership structure.

11. How Is Kenvue Organized?

At a practical level, Kenvue is organized around global product categories supported by regional commercial execution and central corporate functions.

• Reported segments. Kenvue’s official reportable segments are Self Care, Skin Health and Beauty, and Essential Health.
• Geographic execution. Within those categories, local and regional teams handle pricing, retailer relationships, regulation, and market activation.
• Shared functional capabilities. Supply chain, procurement, finance, legal, people, technology, quality, and regulatory functions support the operating businesses.
• Legal structure. Kenvue Inc. is the public parent, with operating subsidiaries in different countries and jurisdictions.

This is not a franchise model and not a loose holding company. It is a centrally managed branded consumer health company that needs enough global coordination to protect quality, brands, and scale benefits, while still allowing local adaptation in regulation, assortment, and media.

12. How Does Kenvue Operate?

Kenvue’s day-to-day operating model is a sequence of brand management, regulated product development, sourcing, manufacturing, selling, and replenishment.

1. Identify consumer and channel opportunities. Category teams analyze demand trends, competitive moves, price gaps, and whitespace for brands and formats.
2. Develop or refine products. Teams work on formulas, packaging, claims support, quality testing, and regulatory compliance, especially for OTC medicines and products with efficacy claims.
3. Source ingredients, packaging, and manufacturing capacity. Kenvue relies on a mix of internal sites and third parties, supported by procurement and quality oversight.
4. Plan demand and inventory. This is especially important in seasonal categories such as allergy and cough/cold, and in promotion-heavy categories such as skin care and oral care.
5. Sell into channels and support sell-through. Commercial teams negotiate with retailers and distributors, manage promotions, and monitor shelf execution and replenishment.
6. Measure performance and reinvest. Management tracks brand health, margins, cash, innovation results, and supply reliability, then reallocates spending across brands, markets, and channels.

The main operational complexities are not those of heavy industry. They are brand and channel complexity, regulatory compliance for OTC products, forecasting seasonal demand, managing global formulas and packaging, maintaining quality, and preserving service levels while improving margins.

13. What Are the Growth Opportunities for Kenvue?

The most plausible growth opportunities for Kenvue are largely consistent with what management has discussed publicly, with some additional synthesis based on the business mix.

• Recovering and reaccelerating Skin Health and Beauty. This is one of the clearest internal opportunities. Better execution, better launches, and better digital merchandising in facial care and related categories could improve both sales growth and mix.
• International expansion of proven brands. Kenvue already operates globally, but several brands still have room to expand across emerging markets and in premium urban channels.
• E-commerce and omnichannel growth. Better digital shelf management, pack architecture, retailer media, and search optimization can lift conversion and market share without requiring a new business model.
• Innovation and premiumization. New formulations, dermatologist-facing or science-led skin care, premium oral care, and adjacent OTC formats can raise average selling prices and improve mix.
• Revenue growth management. Smarter price-pack architecture, promotion discipline, assortment rationalization, and channel-specific pricing can improve revenue quality even in slower-growth categories.
• Selective portfolio shaping. Over time, Kenvue could use licensing, partnerships, tuck-in acquisitions, or divestitures to sharpen focus around its highest-return brands and categories, although the company has not behaved like an aggressive roll-up acquirer.

The main constraints are retailer bargaining power, private-label pressure, regulatory complexity, foreign exchange, input-cost volatility, and execution risk during the standalone build-out. In short, Kenvue has meaningful growth levers, but most of them are execution-heavy rather than purely structural.

14. What Is the History of Kenvue?

Kenvue as an independent company is new, but the business it contains is old. It was created by Johnson & Johnson as the standalone home for J&J’s Consumer Health business and became public through an initial public offering in 2023, followed by Johnson & Johnson’s share exchange that distributed most of its remaining stake.

The deeper roots lie in the Johnson & Johnson system, which was founded in 1886 by Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson. Over decades, that consumer health portfolio accumulated heritage brands in baby care, wound care, oral care, pain relief, skin care, and allergy. Several brands and platforms that now sit inside Kenvue came through acquisition while the business was still part of Johnson & Johnson.

• 2006: Johnson & Johnson acquired Pfizer Consumer Healthcare, adding significant OTC and oral care assets to the future Kenvue portfolio.
• 2016: Johnson & Johnson acquired Vogue International, bringing OGX and Maui Moisture into the hair care portfolio.
• 2018: Johnson & Johnson acquired Zarbee’s Naturals, strengthening the self-care offering.
• 2019: Johnson & Johnson acquired Ci:z Holdings, parent of Dr.Ci:Labo, expanding premium skin care exposure in Japan and Asia.
• 2023: Kenvue completed its IPO and became a standalone consumer health company.

So while Kenvue’s corporate life began recently, its portfolio is a mix of century-old legacy brands and more recent acquired growth brands.

15. What Are the Key Suppliers to Kenvue?

Suppliers matter to Kenvue because its products combine regulated ingredients, consumer-facing packaging, and retail service-level requirements. The company does not publicly identify a single dominant supplier base in detail, but the important categories are clear.

• Active ingredients and excipients. For OTC products, Kenvue needs reliable supplies of active pharmaceutical ingredients and formulation components that meet strict quality and regulatory standards.
• Skin care and personal care ingredients. Surfactants, moisturizers, fragrances, preservatives, botanicals, and specialty chemicals matter for product performance and claims support.
• Packaging suppliers. Bottles, caps, pumps, tubes, blister packs, cartons, labels, and tamper-evident materials are critical because packaging affects cost, compliance, branding, and shelf appeal.
• Contract manufacturers and packagers. External manufacturing partners likely play a role in flexibility, regional reach, and surge capacity.
• Logistics and warehousing providers. These suppliers matter because Kenvue must maintain product availability across global retail networks.
• Technology and services vendors. As a standalone company, Kenvue also depends on enterprise software, data, and support vendors to replace legacy Johnson & Johnson systems.

Supplier structure matters strategically because a failure in quality, packaging availability, or contract manufacturing can quickly affect shelf availability, regulatory compliance, and brand trust.

16. What Are the Key Brands Owned by Kenvue?

Brand ownership is one of Kenvue’s biggest strategic advantages. The company is not just selling generic formulations; it is monetizing a portfolio of highly recognized consumer health names.

For Kenvue, branding is not a cosmetic overlay. It is a core strategic lever that supports pricing, shelf access, repeat purchase, and international scalability.

17. How Does the Supply Chain of Kenvue Function?

Kenvue’s supply chain sits between consumer packaged goods and regulated healthcare. It has to deliver cost, service, compliance, and product integrity at the same time.

1. Sourcing. Ingredients, active compounds, packaging materials, and third-party services are sourced globally under quality and regulatory controls.
2. Manufacturing and packaging. Products are made through a combination of company-owned facilities and external partners, depending on category and region.
3. Quality release and compliance. OTC and personal care products require testing, documentation, and release processes that are more demanding than ordinary consumer goods.
4. Inventory planning. The company must forecast seasonal spikes, retailer promotions, and local market demand while avoiding excess inventory.
5. Distribution. Products move through warehouses and logistics partners to retailers, pharmacies, and distributors worldwide.
6. Replenishment and service. Once products are on shelves, the supply chain has to support in-stock rates, fast replenishment, and promotional events without undermining margins.

Supply-chain reliability is strategically important because Kenvue sells trusted brands in categories where out-of-stock conditions can quickly send consumers to competitors or private label. This is also an area where procurement, planning, and network optimization work can materially improve margins.

18. What Is the R&D Strategy of Kenvue?

Kenvue’s R&D strategy is different from pharmaceutical discovery. It is not built around blockbuster drug pipelines. Instead, it is built around formulation science, safety, efficacy support, claims substantiation, packaging, and consumer-relevant innovation.

• Support trusted product claims. In OTC, oral care, and skin health, the company needs scientific and regulatory support for efficacy and safety claims. That makes R&D a commercial enabler, not just a laboratory function.
• Develop line extensions and improved formulations. Innovation often takes the form of new delivery systems, better sensory profiles, gentler formulas, premium formats, or adjacent use cases.
• Bridge consumer insight and regulation. Kenvue has to translate what consumers want into products that can be made consistently and sold compliantly across markets.
• Protect brand credibility. For brands such as Neutrogena, Aveeno, Listerine, Tylenol, and Nicorette, product performance is tightly linked to brand trust, so weak R&D execution would directly harm the franchise.

The strategic point is that Kenvue’s R&D is not optional overhead. It is one of the systems that allows old brands to keep earning consumer relevance in modern categories.

19. What Is the Finance Strategy of Kenvue?

Kenvue’s finance strategy appears designed to support four priorities: fund brand investment, preserve balance-sheet flexibility, improve margins as a standalone company, and return some cash to shareholders.

• Support profitable growth. The company needs to keep investing in media, innovation, digital commerce, and commercial execution rather than maximize short-term margin at the expense of brands.
• Manage leverage and liquidity prudently. As a recently separated company, Kenvue has to balance shareholder returns with debt service and financial flexibility.
• Improve operating efficiency. Margin expansion depends on productivity, procurement savings, overhead control, and reducing the friction that often follows a corporate separation.
• Maintain cash generation and working-capital discipline. Consumer health can be highly cash generative, but only if inventories, receivables, and promotions are controlled carefully.
• Operate as a dividend-paying branded health company. Kenvue has positioned itself more like a branded consumer staples and healthcare hybrid than a high-burn growth company, which shapes investor expectations around consistency and capital allocation.

Finance strategy therefore supports the broader corporate strategy by giving Kenvue room to invest in core brands while still improving the economic profile of the standalone business.

20. What Major Acquisitions Has Kenvue Made?

Kenvue itself has had limited time to build a standalone acquisition record since its 2023 separation. The more important point is that the portfolio it inherited includes several meaningful acquisitions made while the business was still inside Johnson & Johnson.

• Pfizer Consumer Healthcare (2006). This was strategically important because it added major consumer health brands and broadened the OTC and oral care footprint that now sits inside Kenvue.
• Vogue International (2016). Brought OGX and Maui Moisture into the portfolio, expanding Kenvue’s reach in hair care.
• Zarbee’s Naturals (2018). Added a differentiated self-care brand, particularly relevant in family health and natural-positioned wellness products.
• Ci:z Holdings / Dr.Ci:Labo (2019). Expanded premium skin care exposure and strengthened Kenvue’s position in Japan and parts of Asia.

Through FY2024, Kenvue did not appear to be relying on large-scale M&A as a central standalone growth engine. Historically, acquisitions have been selective and portfolio-shaping rather than constant and transformational.

21. How Companies Like Kenvue Leverage Independent Consultants through Umbrex

Umbrex has grown a global community of over 8,000 independent management consultants who are based in more than 50 countries. These consultants are alums of McKinsey, Bain, BCG, and other top consulting firms. Companies like Kenvue engage Umbrex when they need talent with the training these top global firms provide but they do not need a full team with all the overhead. Umbrex has consultants across Strategy, Operations, Organization, Marketing, Sales, Finance, Technology, ERP, and AI. For a company with Kenvue’s mix of brand management, channel complexity, post-separation work, and margin pressure, the most useful projects are usually tightly scoped and execution-oriented.

1. Design a U.S. Skin Health and Beauty turnaround plan for brands such as Neutrogena and Aveeno, including assortment, pricing, retailer activation, and digital shelf priorities.
2. Build a revenue growth management program covering price-pack architecture, promotion effectiveness, and channel-specific margin analysis across OTC and essential health categories.
3. Support post-separation operating-model work, including transition-service exit planning, shared-services design, and governance for standalone functions.
4. Run a global supply-chain and inventory optimization project focused on seasonal demand planning, service levels, and working-capital reduction.
5. Develop an e-commerce acceleration plan covering retailer media, content strategy, search optimization, ratings and reviews, and omnichannel pack architecture.
6. Prioritize the innovation pipeline by brand and geography, helping management decide which line extensions, reformulations, and premium concepts deserve funding.
7. Assess international growth opportunities by market, especially where Kenvue can extend existing brands into faster-growing channels or underpenetrated geographies.
8. Lead a portfolio review to identify low-return SKUs, non-core brands, or markets where simplification could improve gross margin and management focus.
9. Execute a procurement and cost-of-goods program targeting packaging, external manufacturing, and logistics savings without weakening quality or service.
10. Design AI-enabled demand forecasting, trade-spend analytics, or commercial dashboards that help management improve forecast accuracy and channel decisions.